Design, synthesis, and evaluation of a new class of noncyclic 1,3-dicarbonyl compounds as PPARα selective activators
- 8 May 2004
- journal article
- research article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 14 (13), 3507-3511
- https://doi.org/10.1016/j.bmcl.2004.04.053
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- PPAR Ligands for Metabolic DisordersCurrent Topics in Medicinal Chemistry, 2003
- Peroxisome-Proliferator-Activated Receptor δ Activates Fat Metabolism to Prevent ObesityCell, 2003
- PPARgamma agonists in the treatment of type II diabetes: is increased fatness commensurate with long-term efficacy?International Journal of Obesity, 2003
- Up-Regulation of Uncoupling Protein 3 Gene Expression by Fatty Acids and Agonists for PPARs in L6 MyotubesEndocrinology, 2001
- Skeletal Muscle TriglycerideDiabetes Care, 2001
- A selective peroxisome proliferator-activated receptor δ agonist promotes reverse cholesterol transportProceedings of the National Academy of Sciences, 2001
- Alterations of Peroxisome Proliferator-activated Receptor δ Activity Affect Fatty Acid-controlled Adipose DifferentiationPublished by Elsevier ,2000
- The PPARs: From Orphan Receptors to Drug DiscoveryJournal of Medicinal Chemistry, 2000
- Sulfated Glycans Stimulate Endocytosis of the Cellular Isoform of the Prion Protein, PrPC, in Cultured CellsJournal of Biological Chemistry, 1995
- Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferatorsNature, 1990